Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs7985716 | chr13:54170860 | T/A | 0.000228 | 177 | 25.77 | 20.17 | 3.17 | KM Plot |
PCPG | rs79893240 | chr2:176156442 | A/G | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
PCPG | rs7990278 | chr13:64105474 | T/C | 3.05E-5 | 177 | 22.63 | 21.55 | 26.57 | KM Plot |
PCPG | rs7991057 | chr13:37579282 | A/T | 0.000285 | 178 | 4.17 | 24.7 | 25.7 | KM Plot |
PCPG | rs7992180 | chr13:54101741 | C/T | 0.000255 | 176 | 25.53 | 19.72 | 3.17 | KM Plot |
PCPG | rs79951144 | chr17:1418565 | G/A | 1.37E-5 | 176 | 24.7 | 25.87 | 13.02 | KM Plot |
PCPG | rs79962550 | chr2:61587303 | T/TA | 6.43E-5 | 178 | 23.43 | 29.88 | 10.3 | KM Plot |
PCPG | rs79976723 | chr10:131987377 | G/A | 0 | 174 | 25.53 | 25.33 | 3.17 | KM Plot |
PCPG | rs79977946 | chr7:66340755 | C/T | 0.000217 | 178 | 24.7 | 29.57 | 33.17 | KM Plot |
PCPG | rs79997424 | chr7:33697028 | C/T | 1.12E-7 | 177 | 25.28 | 25.43 | 19.87 | KM Plot |
PCPG | rs8000534 | chr13:37547009 | A/G | 0.000337 | 176 | 4.17 | 24.17 | 25.87 | KM Plot |
PCPG | rs8000651 | chr13:54234870 | G/A | 0.000367 | 170 | 25.87 | 29.43 | 3.17 | KM Plot |
PCPG | rs80009529 | chr16:71719013 | G/A | 8.89E-6 | 175 | 23.83 | 32.03 | 14.5 | KM Plot |
PCPG | rs8002516 | chr13:54135020 | A/G | 0.000244 | 176 | 25.67 | 19.72 | 3.17 | KM Plot |
PCPG | rs80032725 | chr16:90065555 | AGCCACCTACTCCT/A | 9.47E-9 | 173 | 25.77 | 20.37 | 6.62 | KM Plot |